Here come the Swiss!

























I don't know. They just stopped 3 trials in their pipeline and Alexions is strong. Pricy but strong and they want orphans for the fast tracking and long hold without generic. If they can cough up the cash - street says anywhere fro 130-200. Could be a good thing.